A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors
Clinical trial NCT05141240 · COMPLETED
Trial details
- NCT number
- NCT05141240
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-04-15
- Primary completion
- 2020-06-15
- Enrollment
- 4650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.